All Posts

Navigating the new In Vitro Diagnostic Regulation (IVDR Compliance) can feel overwhelming for many biotech and SME companies. The regulation demands thorough documentation, rigorous testing, and clear evidence of safety and performance for in vitro diagnostic devices. Without a clear plan, companies risk delays, costly rework, or even losing market access. That’s why a gap analysis consultation is a crucial step in achieving IVDR compliance efficiently and confidently. Unders

Navigating the transition to the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) is a complex challenge for many biotech and SME companies. These regulations bring stricter requirements and new processes that can impact product development, market access, and compliance. Without expert guidance, companies risk delays, increased costs, or even losing market opportunities. I want to share how expert support can ease this transition, helping you meet re

Navigating the FDA 510k submission process can be challenging, especially for companies based in the UK aiming to enter the US medical device market. Understanding the regulatory landscape and aligning your submission with FDA expectations is crucial for a smooth approval process. In this article, I will share clear, practical guidance tailored for biotech and SME companies in the medical device and pharmaceutical sectors. My goal is to demystify the FDA 510k submission proce

Artificial intelligence (AI) is transforming industries and daily life worldwide. As AI technologies evolve rapidly, governments are working to establish clear rules to ensure these innovations are safe, ethical, and respect fundamental rights. The European Union (EU) is at the forefront of this effort, developing a regulatory framework to govern AI use within its member states.

The first few weeks of 2026 have brought significant developments from the FDA and EMA, from landmark AI collaborations to proactive measures for strengthening domestic manufacturing and securing drug supplies.

Artificial intelligence (AI) is transforming the medical device and pharmaceutical industries at an unprecedented pace. For biotech and SME companies, leveraging AI offers exciting opportunities to innovate and improve patient outcomes. However, navigating the evolving regulatory landscape is critical to ensure compliance, safety, and market access. The European Union’s AI regulations represent a landmark framework designed to govern AI technologies responsibly. Understanding

Navigating the regulatory landscape for medical devices in Europe can seem daunting. However, with a clear understanding of the process and requirements, it becomes manageable and straightforward. I will guide you through the essential steps to register your medical device in Europe, ensuring compliance and smooth market entry. This knowledge is crucial for biotech and SME companies aiming to bring innovative medical products to patients efficiently and safely. Understanding

Navigating the complex world of global regulatory compliance can feel overwhelming, especially for biotech and SME companies in the medical device and pharmaceutical sectors. The landscape is constantly evolving, with diverse regulations across regions that demand precision, agility, and deep expertise. My goal is to demystify this process and provide you with clear, actionable insights to help your organisation thrive in this challenging environment. Understanding Global Reg

Bringing a medical device to market is a journey filled with regulatory checkpoints, documentation, and strategic decisions. As someone deeply involved in regulatory affairs, I understand how daunting this process can be, especially for biotech and SME companies striving to innovate while ensuring patient safety. The medical device approval process is not just a bureaucratic hurdle; it is a critical pathway that ensures every device meets stringent standards before reaching p

Understanding the Regulatory Landscape with Medical Device Consulting Services. Regulations vary by region, but the core principles remain consistent: safety, efficacy, and quality. For example, in the UK and Europe, the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) set stringent requirements. In the US, the FDA’s Quality System Regulation (QSR) governs device manufacturing and controls.

Navigating the regulatory landscape for medical devices in Europe can feel daunting. However, with the right approach and clear understanding, it becomes a manageable process that opens doors to one of the world’s most significant healthcare markets. I want to share practical insights and step-by-step guidance to help you confidently move through the process of registering medical devices in Europe. This will empower your company to bring innovative products to patients faste

Entering the UK medical device market is a significant milestone for any biotech or SME company. The pathway to market access can seem complex, but with the right approach, it becomes a manageable and strategic process. I want to share insights that will help you navigate the regulatory landscape confidently, ensuring your innovative medical devices reach patients efficiently and compliantly.

Navigating the UK medical device market can be a complex journey. For biotech and SME companies, understanding the regulatory landscape is crucial to efficiently and safely bringing innovative products to patients. As someone deeply involved in this field, I know that medical device entry consulting is not just about ticking boxes; it’s about creating a strategic pathway that accelerates market access while ensuring compliance and patient safety.

A well-structured strategy is the backbone of successful international expansion. It involves thorough market research, competitive analysis, and a clear entry plan. Here are the critical steps to consider:

Navigating the complex regulatory compliance landscape in the UK is a critical challenge for biotech and SME companies in the medical device and pharmaceutical sectors. As someone deeply involved in this field, I understand how essential it is to have a trusted partner who can guide you through the intricacies of regulations, ensuring your innovations reach patients safely and efficiently. Regulatory affairs play a pivotal role in this process, acting as the bridge between yo

Why FDA Compliance Consulting is Essential for UK Biotech and SME Companies. For biotech and SME companies, resources are often limited, and regulatory missteps can be costly. FDA compliance consulting offers tailored support that aligns with your business goals and product innovation timelines.

The EU AI Act (Artificial Intelligence Act Regulation EU 2024/1689), which came into force on 1 August 2024, establishes a harmonised framework for regulating AI systems. It impacts the use of AI in medical settings, particularly when integrated with the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR).

In this article, we will explore how AI is reshaping the pharmaceutical landscape and examine its implications for the workforce, presenting a balanced view on the potential benefits and challenges ahead.

The pharmaceutical industry in Mexico is on the brink of significant change thanks to the reliance regulatory pathway introduced by the Federal Commission for the Protection against Sanitary Risks (COFEPRIS). This new approach is designed to make the approval processes for clinical research protocols

Navigating the Future of Artificial Intelligence (AI) into Neurotechnology and medical technology (MedTech) is poised to revolutionise healthcare, offering unprecedented diagnostic and therapeutic capabilities.